Structural Neuroimaging in Aging and Alzheimer's Disease

被引：26
|
作者：
Vernooij, Meike W. [1 ,2 ]
Smits, Marion [1 ]
机构：
[1] Erasmus MC, Dept Radiol, Univ Med Ctr, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus MC, Dept Epidemiol, Univ Med Ctr, NL-3000 CA Rotterdam, Netherlands
来源：
NEUROIMAGING CLINICS OF NORTH AMERICA | 2012年 / 22卷 / 01期
关键词：
Dementia; Alzheimer's disease; Magnetic resonance (MR) imaging; Normal aging; Brain; Atrophy; Neuroimaging; POSTERIOR CORTICAL ATROPHY; VIRCHOW-ROBIN SPACES; WHITE-MATTER HYPERINTENSITIES; ENLARGED PERIVASCULAR SPACES; MILD COGNITIVE IMPAIRMENT; CREUTZFELDT-JAKOB-DISEASE; MAGNETIC-RESONANCE IMAGES; MEDIAL TEMPORAL-LOBE; SMALL VESSEL DISEASE; CEREBRAL MICROBLEEDS;
D O I：
10.1016/j.nic.2011.11.007
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
The role of structural neuroimaging in the diagnosis of Alzheimer's disease (AD) is becoming increasingly important. As a consequence, a basic understanding of what are normal brain changes in aging is key to be able to recognize what is abnormal. The first part of this article discusses normal versus pathologic brain aging, focusing on qualitative and quantitative magnetic resonance (MR) imaging markers. In the second part, the role of MR imaging in the (differential) diagnosis of AD is reviewed.
引用
收藏
页码：33 / +
页数：25
相关论文
共 50 条
  • [41] A review of β-amyloid neuroimaging in Alzheimer's disease
    Adlard, Paul A.
    Tran, Bob A.
    Finkelstein, David I.
    Desmond, Patricia M.
    Johnston, Leigh A.
    Bush, Ashley I.
    Egan, Gary F.
    FRONTIERS IN NEUROSCIENCE, 2014, 8
  • [42] Neuroimaging of vessel amyloid in Alzheimer's disease
    Friedland, RP
    Kalaria, R
    Berridge, M
    Miraldi, F
    Hedera, P
    Reno, J
    Lyle, L
    Marotta, CA
    CEREBROVASCULAR PATHOLOGY IN ALZHEIMER'S DISEASE, 1997, 826 : 242 - 247
  • [43] Integrated transcriptomic and neuroimaging brain model decodes biological mechanisms in aging and Alzheimer's disease
    Adewale, Quadri
    Khan, Ahmed F.
    Carbonell, Felix
    Iturria-Medina, Yasser
    ELIFE, 2021, 10
  • [44] A review of neuroimaging biomarkers of Alzheimer's disease
    Varghese, Tinu
    Sheelakumari, R.
    James, Jija S.
    Mathuranath, P. S.
    NEUROLOGY ASIA, 2013, 18 (03) : 239 - 248
  • [45] Neuroimaging to predict preclinical Alzheimer's disease
    Kumari, V
    Mitterschiffthaler, MT
    Sharma, T
    HOSPITAL MEDICINE, 2002, 63 (06): : 341 - 345
  • [46] Neuroimaging Biomarkers of mTOR Inhibition on Vascular and Metabolic Functions in Aging Brain and Alzheimer's Disease
    Lee, Jennifer
    Yanckello, Lucille M.
    Ma, David
    Hoffman, Jared D.
    Parikh, Ishita
    Thalman, Scott
    Bauer, Bjoern
    Hartz, Anika M. S.
    Hyder, Fahmeed
    Lin, Ai-Ling
    FRONTIERS IN AGING NEUROSCIENCE, 2018, 10
  • [47] Alzheimer's Disease Neuroimaging Initiative in Europe
    Frisoni, Giovanni B.
    ALZHEIMERS & DEMENTIA, 2010, 6 (03) : 280 - 285
  • [48] Neuroimaging Studies in Alzheimer's Disease A Review
    Cuellar, H.
    Gomez-Ramos, P.
    Riascos, R.
    De Alba, L.
    NEURORADIOLOGY JOURNAL, 2009, 22 (05): : 525 - 533
  • [49] STRUCTURAL IMAGING OF HIPPOCAMPAL SUBFIELDS IN HEALTHY AGING AND ALZHEIMER'S DISEASE
    De Flores, Robin
    La Joie, Renaud
    Chetelat, Gael
    NEUROSCIENCE, 2015, 309 : 29 - 50
  • [50] Interactions Between Aging and Alzheimer's Disease on Structural Brain Networks
    Wu, Zhanxiong
    Gao, Yunyuan
    Potter, Thomas
    Benoit, Julia
    Shen, Jian
    Schulz, Paul E.
    Zhang, Yingchun
    FRONTIERS IN AGING NEUROSCIENCE, 2021, 13
12345